XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities:    
Net increase (decrease) in net assets resulting from operations $ 35,748,138 $ 85,882,073
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:    
Net realized (gains)/losses on investments 18,267,554 2,423,632
Net change in unrealized (gains)/losses on investments (6,210,881) (45,708,992)
Net accretion of discount on investments (1,405,048) (1,221,531)
Payment-in-kind interest (439,129) 0
Purchases of short-term investments (671,362,722) (460,682,481)
Purchases of portfolio investments (602,024,188) (188,402,217)
Proceeds from sale of short-term investments 689,778,454 411,655,942
Proceeds from sale of portfolio investments 292,405,569 194,434,792
Amortization of deferred financing cost 1,133,298 747,093
Increase/(decrease) in operating assets and liabilities:    
(Increase)/decrease in receivable for sales of investments (8,550,514) 23,462,037
(Increase)/decrease in interest and dividends receivable (3,533,158) (1,342,924)
(Increase)/decrease in due from investment adviser 1,610,735 (40,618)
(Increase)/decrease in receivable for paydowns of investments (495,977) (146,137)
(Increase)/decrease in prepaid expenses and other assets (109,414) (21,880)
Increase/(decrease) in interest payable on credit facilities 6,455,327 2,524,428
Increase/(decrease) in payable for investments purchased 11,412,860 (7,517,068)
Increase/(decrease) in management fees payable 172,337 324,943
Increase/(decrease) in incentive fee payable 2,229,576 0
Increase/(decrease) in accrued other general and administrative expenses 24,637 (234,402)
Net cash provided by (used in) operating activities (234,892,546) 16,136,690
Cash Flows from Financing Activities:    
Borrowings on the credit facilities 211,729,239 16,500,000
Payments on the credit facilities (331,254,150) (28,500,000)
Borrowings on the notes 300,000,000 0
Payments of debt issuance costs (5,480,747) (32,114)
Distributions paid in cash (31,257,549) (19,998,995)
Proceeds from issuance of common shares, net of change in subscriptions receivable 89,652,500 17,654,225
Purchase of common shares for dividend reinvestment plan 1,668,707 0
Repurchase of common shares (496,764) 0
Net cash provided by (used in) financing activities 234,561,236 (14,376,884)
Net increase/(decrease) in cash and cash equivalents (331,310) 1,759,806
Cash and cash equivalents, beginning of period 2,117,109 1,650,801
Cash and cash equivalents, end of period 1,785,799 3,410,607
Supplemental and Non-Cash Information:    
Interest paid during the period 37,391,169 30,173,089
Distributions declared during the period 46,590,819 41,790,566
Reinvestment of distributions during the period 0 21,670,380
Distributions payable $ 15,333,270 $ 7,062,257